Efficacy and safety of preoperative 5-fluorouracil, cisplatin, and mitomycin C in combination with radiotherapy in patients with resectable and borderline resectable pancreatic cancer: a long-term follow-up study
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and safety of preoperative 5-fluorouracil, cisplatin, and mitomycin C in combination with radiotherapy in patients with resectable and borderline resectable pancreatic cancer: a long-term follow-up study
Authors
Keywords
Chemoradiotherapy, Follow-up studies, Neoadjuvant therapy, Pancreatic carcinoma
Journal
World Journal of Surgical Oncology
Volume 17, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-08-17
DOI
10.1186/s12957-019-1687-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After
- (2017) Claudio Bassi et al. SURGERY
- Clinical predictive factors of long-term survival after curative resection of pancreatic cancer: a retrospective study
- (2017) Yutaka Nakano et al. Cancer Medicine
- Neoadjuvant Therapy for Pancreatic Cancer
- (2016) Vivek Verma et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Cancer treatment and survivorship statistics, 2016
- (2016) Kimberly D. Miller et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)
- (2016) Katsuhiko Uesaka et al. LANCET
- Efficacy of Neo-Adjuvant Chemoradiotherapy for Resectable Pancreatic Adenocarcinoma
- (2016) Wei Liu et al. MEDICINE
- Survival of patients with resectable pancreatic cancer who received neoadjuvant therapy
- (2016) Kathleen K. Christians et al. SURGERY
- Does the Use of Neoadjuvant Therapy for Pancreatic Adenocarcinoma Increase Postoperative Morbidity and Mortality Rates?
- (2014) Amanda B. Cooper et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Clinical and pathological features of five-year survivors after pancreatectomy for pancreatic adenocarcinoma
- (2014) Kenjiro Kimura et al. World Journal of Surgical Oncology
- Neoadjuvant Chemotherapy with Gemcitabine and S-1 for Resectable and Borderline Pancreatic Ductal Adenocarcinoma: Results from a Prospective Multi-institutional Phase 2 Trial
- (2013) Fuyuhiko Motoi et al. ANNALS OF SURGICAL ONCOLOGY
- Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer
- (2013) Helmut Oettle et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Role of the FOLFIRINOX Regimen for Advanced Pancreatic Cancer
- (2013) Thierry Conroy et al. Current Oncology Reports
- Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer?
- (2012) Katia T. Papalezova et al. JOURNAL OF SURGICAL ONCOLOGY
- Japan Pancreatic Cancer Registry; 30th Year Anniversary
- (2012) Shinichi Egawa et al. PANCREAS
- Significance of Pathologic Response to Preoperative Therapy in Pancreatic Cancer
- (2011) Yun Shin Chun et al. ANNALS OF SURGICAL ONCOLOGY
- Effect of Neoadjuvant Chemoradiation and Surgical Technique on Recurrence of Localized Pancreatic Cancer
- (2011) Matthew H. G. Katz et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Beneficial Effects of 5-Fluorouracil and Heparin-Based Portal Infusion Chemotherapy Combined with Mitomycin C and Cisplatin after Curative Resection of Pancreatic Cancer
- (2010) Koichi Aiura et al. PANCREATOLOGY
- Feasibility and Efficacy of Combination Therapy With Preoperative Full-Dose Gemcitabine, Concurrent Three-Dimensional Conformal Radiation, Surgery, and Postoperative Liver Perfusion Chemotherapy for T3-Pancreatic Cancer
- (2009) Hiroaki Ohigashi et al. ANNALS OF SURGERY
- Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma
- (2009) Matthew H. G. Katz et al. ANNALS OF SURGICAL ONCOLOGY
- Impact of Venous Thromboembolism and Anticoagulation on Cancer and Cancer Survival
- (2009) Nicole M. Kuderer et al. JOURNAL OF CLINICAL ONCOLOGY
- Neoadjuvant 5 Fluorouracil-Cisplatin Chemoradiation Effect on Survival in Patients with Resectable Pancreatic Head Adenocarcinoma: A Ten-Year Single Institution Experience
- (2009) Olivier Turrini et al. ONCOLOGY
- Neoadjuvant Chemoradiation in Patients With Potentially Resectable Pancreatic Cancer
- (2009) Soichiro Takai et al. PANCREAS
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Preoperative Gemcitabine and Cisplatin Followed by Gemcitabine-Based Chemoradiation for Resectable Adenocarcinoma of the Pancreatic Head
- (2008) Gauri R. Varadhachary et al. JOURNAL OF CLINICAL ONCOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started